Abstract: A lighting device includes a light guide plate configured to guide and diffuse a light from a light source, and a garnish body including a lighting area to which the diffused light is radiated, wherein the light guide plate is disposed at a predetermined angle with respect to the garnish body.

Abstract: An automated method for generating a prosthesis from a 3D scan data, the method includes automatically extracting tooth information of a tooth included in the 3D scan data from the 3D scan data, automatically extracting a margin line of a prepared tooth, generating a plurality of two dimensional (“2D”) images including the prepared tooth and an adjacent tooth adjacent to the prepared tooth, automatically generating a 3D temporary prosthesis data based on the plurality of 2D images and deforming a single tooth model corresponding to the prepared tooth using the margin line and the 3D temporary prosthesis data to generate a 3D prosthesis data.

Abstract: A flexible self-supporting solid electrolyte membrane, an all-solid-state battery including the membrane, and a manufacturing method thereof are disclosed. The solid electrolyte membrane may include: a substrate including pores therein; and a solid electrolyte layer disposed on at least one surface of the substrate and including a solid electrolyte and a cured compound. At least a portion of the solid electrolyte layer may penetrate into the pores of the substrate to form a conduction path of lithium ions in a thickness direction of the substrate.

Abstract: Disclosed are a method and an apparatus of manufacturing an anode for an all-solid-state battery by using an electric field. The manufacturing method includes: preparing a first coating member and a second coating member spaced apart from the first coating member by a predetermined distance; preparing a coating slurry, the coating slurry including a carbon material and a metal alloyable with lithium; feeding the coating slurry to the first coating member; feeding a current collector between the first coating member and the second coating member; and coating the coating slurry on the current collector by using an electric field generated between the first coating member and the second coating member by applying voltages to the first coating member and the second coating member.

Abstract: Provided is a shell-type monitoring apparatus. The shell-type monitoring apparatus includes a body, a gas storage provided in the body and configured to store a gas, a variable volume portion provided on the gas storage in the body and having a volume that varies depending on an amount of gas supplied from the gas storage, a photographing unit provided on the body and configured to move in the body, and a moving flow path provided in the body and configured to supply the gas in the variable volume portion to the photographing unit and thereby move the photographing unit.

Abstract: Provided is a shell-type monitoring apparatus. The shell-type monitoring apparatus includes a body, a gas storage provided in the body and configured to store a gas, a variable volume portion provided on the gas storage in the body and having a volume that varies depending on an amount of gas supplied from the gas storage, a photographing unit provided on the body and configured to move in the body, and a moving flow path provided in the body and configured to supply the gas in the variable volume portion to the photographing unit and thereby move the photographing unit.

Abstract: There is provided a firearm assembly including: a base; a firearm coupling unit configured to move forward or backward with respect to the base; an elastic support unit configured to elastically support the firearm coupling unit; and a firearm mounted on the firearm coupling unit and including: a bolt assembly configured to move backward or forward; and a return spring configured to elastically support the bolt assembly, wherein upon firing the firearm, the firearm coupling unit is configured to return to a coupling unit original forward position after completion of the bolt assembly returning to a bolt assembly original forward position.

Abstract: There is provided a firearm assembly including: a base; a firearm coupling unit configured to move forward or backward with respect to the base; an elastic support unit configured to elastically support the firearm coupling unit; and a firearm mounted on the firearm coupling unit and including: a bolt assembly configured to move backward or forward; and a return spring configured to elastically support the bolt assembly, wherein upon firing the firearm, the firearm coupling unit is configured to return to a coupling unit original forward position after completion of the bolt assembly returning to a bolt assembly original forward position.

Abstract: Provided is a sustained-release formulation: (a) a sustained-release core including an active ingredient and a polymer having erosion and swelling property in mammalian intestinal secretions, (b) an enteric film coating layer coated on the sustained-release core, and (c) an active ingredient-containing film coating layer coated on the enteric film coating layer and including the active ingredient and hydrophilic polymer for film coating.

Abstract: Provided is a method of preparing low-crystallinity oltipraz or amorphous oltipraz. The method includes: obtaining a mixed solution containing oltipraz and a water-soluble polymer or a water-insoluble polymer in a solvent, the solvent being an organic solvent or purified water; and solid-dispersing the oltipraz in the polymer. In the solid-dispersing, the mixed solution may be spray dried using a spray dryer or granulated using a fluid bed granulator.

Abstract: A therapeutic agent based on a recombinant adenovirus which employs an osteocalcin promoter for the expression of thymidine kinase can be administered intravascularly to treat metastatic cancer, including osteosarcoma, breast cancer, prostate cancer, ocular melanoma or brain cancer. Systemic administration of this agent provides a preferred route over previous disclosure of local direct administration. The same therapeutic agent can be effectively employed in the treatment of benign conditions, including benign prostatic hypertrophy and arteriosclerosis.

Abstract: This invention is concerned with the clinical investigation of the therapeutic effects of garlic extracts containing allicin, diallyl disulfide, and diallyl trisulfide. The intake of garlic or therapeutically active substances such as allicin from garlic, induces immunostimulation and these active substances possess strong antitumor effects including the apoptosis of tumors, including the programmed cell death of human prostatic and bladder tumor cells. This invention claims that garlic and/or garlic extracts possess very effective therapeutic substances useful not only to treat human prostate and bladder cancers to extend life span of patients, but also to suppress or prevent bladder and prostate gland cancers.

Abstract: This invention is concerned with clinical investigation of therapeutic effects of garlic extracts containing allicin, diallyl disulfide, and diallyl trisulfide. Because the intake of garlic or therapeutically active substance such as allicin from garlic, induces immunostimulation and possess strong antitumor effects concomitant with apoptosis of tumors that can in turn induces a programmed cell death of human prostatic and bladder tumor cells. This invention claims that garlic and/or garlic extracts possess very effective therapeutic substances not only to treat human prostate and bladder cancers to extend life span of patients, but also to suppress or prevent bladder and prostate gland cancers.

Abstract: A therapeutic agent based on a recombinant adenovirus which employs an osteocalcin promoter for the expression of thymidine kinase can be administered intravascularly to treat metastatic cancer, including osteosarcoma, breast cancer, prostate cancer, ocular melanoma or brain cancer. Systemic administration of this agent provides a preferred route over previous disclosure of local direct administration. The same therapeutic agent can be effectively employed in the treatment of benign conditions, including benign prostatic hypertrophy and arteriosclerosis.

Abstract: A recombinant adenovirus Ad-OC-TK was constructed, with cell specific gene expression, which contains osteocalcin (OC) promoter that drives the expression of herpes simplex virus thymidine kinase (TK); the addition of acyclovir (ACV), a pro-drug for the inhibition of cell proliferation, to Ad-OC-TK resulted in the induction of osteoblast-specific cell death in vitro. The Ad-OC-TK virus plus ACV treatment is highly selective in blocking the growth of both murine and human osteosarcoma cell lines in vitro and murine osteosarcoma in vivo.